{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:35:34Z","timestamp":1762508134847,"version":"build-2065373602"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.tcm.2020.06.007","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:44:09Z","timestamp":1593218649000},"page":"361-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Management of atrial fibrillation after transcatheter aortic valve replacement: Challenges and therapeutic considerations"],"prefix":"10.1016","volume":"31","author":[{"given":"Ahmed","family":"Ammar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed I.","family":"Elbatran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadeev","family":"Wijesuriya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bunny","family":"Saberwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Y.","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.tcm.2020.06.007_bib0001","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.tcm.2020.06.007_bib0002","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation","volume":"33","author":"John Camm","year":"2012","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.tcm.2020.06.007_bib0003","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jacc.2006.10.062","article-title":"Mortality trends in patients diagnosed with first atrial fibrillation. A 21-year community-based study","volume":"49","author":"Miyasaka","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.tcm.2020.06.007_bib0004","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2020.06.007_bib0005","doi-asserted-by":"crossref","unstructured":"Mentias A, Saad M, Girotra S, Desai M, Elbadawi A, Briasoulis A, et\u00a0al. Impact of pre-existing and new onset atrial fibrillation on outcomes after transcatheter aortic valve replacement. 2019;1\u201310.","DOI":"10.1016\/j.jcin.2019.06.019"},{"issue":"9","key":"10.1016\/j.tcm.2020.06.007_bib0006","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1910555","article-title":"Five-year outcomes of transcatheter or surgical aortic-valve replacement","volume":"382","author":"Makkar","year":"2020","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.tcm.2020.06.007_bib0007","first-page":"1285","article-title":"Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: Epidemiology, timing, predictors, and outcome","volume":"38","author":"Tarantini","year":"2017","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.tcm.2020.06.007_bib0008","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jcin.2016.01.037","article-title":"Prevalence and impact of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement an analysis from the SOURCE XT prospective multicenter registry","volume":"9","author":"Tarantini","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"19","key":"10.1016\/j.tcm.2020.06.007_bib0009","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/eurheartj\/ehs255","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document","volume":"33","author":"Kappetein","year":"2012","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.tcm.2020.06.007_bib0010","doi-asserted-by":"crossref","first-page":"e1047","DOI":"10.4244\/EIJY15M11_12","article-title":"A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation","volume":"12","author":"Sannino","year":"2016","journal-title":"EuroIntervention"},{"issue":"17","key":"10.1016\/j.tcm.2020.06.007_bib0011","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.jcin.2018.05.042","article-title":"Incidence, management, and associated clinical outcomes of new-onset atrial fibrillation following transcatheter aortic valve replacement: an analysis from the STS\/ACC TVT registry","volume":"11","author":"Vora","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2020.06.007_bib0012","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2017.02.098","article-title":"Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement","volume":"234","author":"J\u00f8rgensen","year":"2017","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2020.06.007_bib0013","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.athoracsur.2011.08.078","article-title":"Postprocedural atrial fibrillation after transcatheter aortic valve implantation versus surgical aortic valve replacement","volume":"93","author":"Motloch","year":"2012","journal-title":"Ann Thorac Surg [Internet]"},{"issue":"2","key":"10.1016\/j.tcm.2020.06.007_bib0014","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jacc.2011.09.061","article-title":"Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation","volume":"59","author":"Amat-Santos","year":"2012","journal-title":"J Am Coll Cardiol [Internet]"},{"issue":"7","key":"10.1016\/j.tcm.2020.06.007_bib0015","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.amjcard.2018.12.041","article-title":"Incidence, predictors, management, and clinical significance of new-onset atrial fibrillation after transcatheter aortic valve implantation","volume":"123","author":"Yoon","year":"2019","journal-title":"Am J Cardiol [Internet]"},{"issue":"1","key":"10.1016\/j.tcm.2020.06.007_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCINTERVENTIONS.115.002766","article-title":"Atrial fibrillation is associated with increased mortality in patients undergoing transcatheter aortic valve replacement: Insights from the placement of aortic transcatheter valve (partner) trial","volume":"9","author":"Biviano","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2020.06.007_bib0017","first-page":"41","article-title":"New-onset atrial fibrillation after surgical aortic valve replacement and transcatheter aortic valve implantation: a concise review","volume":"27","author":"J\u00f8rgensen","year":"2015","journal-title":"J. Invasive Cardiol"},{"issue":"15","key":"10.1016\/j.tcm.2020.06.007_bib0018","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jacc.2013.11.046","article-title":"New-onset atrial fibrillation after aortic valve replacement: comparison of transfemoral, transapical, transaortic, and surgical approaches","volume":"63","author":"Tanawuttiwat","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.tcm.2020.06.007_bib0019","first-page":"407","article-title":"Assessment of inflammatory response to transfemoral transcatheter aortic valve implantation compared to transapical and surgical procedures: a pilot study","volume":"24","author":"St\u00e4hli","year":"2012","journal-title":"J Invasive Cardiol"},{"issue":"11","key":"10.1016\/j.tcm.2020.06.007_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143089","article-title":"Technical approach determines inflammatory response after surgical and transcatheter aortic valve replacement","volume":"10","author":"Erdoes","year":"2015","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.tcm.2020.06.007_bib0021","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/heartjnl-2012-302185","article-title":"Effect of thoracic epidural analgesia on clinical outcomes following transapical transcatheter aortic valve implantation","volume":"98","author":"Amat-Santos","year":"2012","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.tcm.2020.06.007_bib0022","first-page":"468","article-title":"Predictors and clinical implications of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation","volume":"85","author":"Barbash","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.tcm.2020.06.007_bib0023","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.amjcard.2018.04.029","article-title":"Incidence, predictive factors, and prognostic impact of silent atrial fibrillation after transcatheter aortic valve implantation","volume":"122","author":"Robert","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2020.06.007_bib0024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jacc.2013.02.088","article-title":"Evaluation and management of paravalvular aortic regurgitation after transcatheter aortic valve replacement","volume":"62","author":"Sinning","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.tcm.2020.06.007_bib0025","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jacc.2015.06.026","article-title":"1-year outcomes after transcatheter aortic valve replacement with balloon-expandable versus self-expandable valves: results from the CHOICE randomized clinical trial","volume":"66","author":"Abdel-Wahab","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.tcm.2020.06.007_bib0026","first-page":"180","article-title":"Causes of peri-operative mortality after transcatheter aortic valve implantation: a pooled analysis of 12 studies and 1223 patients","volume":"23","author":"Moreno","year":"2011","journal-title":"J Invasive Cardiol"},{"issue":"Suppl.","key":"10.1016\/j.tcm.2020.06.007_bib0027","doi-asserted-by":"crossref","first-page":"B50","DOI":"10.1093\/eurheartj\/suz016","article-title":"Risk of stroke after transcatheter aortic valve implant: the role of the new oral anticoagulants","volume":"21","author":"Muscente","year":"2019","journal-title":"Eur Hear J"},{"issue":"38","key":"10.1016\/j.tcm.2020.06.007_bib0028","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1093\/eurheartj\/ehu175","article-title":"Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients","volume":"35","author":"Allende","year":"2014","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.tcm.2020.06.007_bib0029","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/eurheartj\/ehn609","article-title":"Atrial fibrillation following cardiac surgery: clinical features and preventative strategies","volume":"30","author":"Kaireviciute","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2020.06.007_bib0030","unstructured":"Franco LN.Prevention of New Onset AF After TAVI (PAF-TAVI Trial) (PAF-TAVI) [Internet]. Available from:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03991754"},{"issue":"1","key":"10.1016\/j.tcm.2020.06.007_bib0031","first-page":"105","article-title":"Conduction abnormalities after transcatheter aortic valve implantation","volume":"15","author":"Karyofillis","year":"2018","journal-title":"J Geriatr Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2020.06.007_bib0032","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jacc.2004.03.057","article-title":"Drug-induced atrioventricular block: pPrognosis after discontinuation of the culprit drug","volume":"44","author":"Zeltser","year":"2004","journal-title":"J Am Coll Cardiol [Internet]"},{"issue":"17","key":"10.1016\/j.tcm.2020.06.007_bib0033","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"issue":"36","key":"10.1016\/j.tcm.2020.06.007_bib0034","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2020.06.007_bib0035","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijcard.2016.11.104","article-title":"Evaluation of current practices in transcatheter aortic valve implantation: the WRITTEN (WoRldwIde TAVI ExperieNce) survey","volume":"228","author":"Cerrato","year":"2017","journal-title":"Int J Cardiol [Internet]"},{"issue":"1","key":"10.1016\/j.tcm.2020.06.007_bib0036","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jacc.2018.08.1045","article-title":"Long-term mortality and early valve dysfunction according to anticoagulation use: the FRANCE TAVI registry","volume":"73","author":"Overtchouk","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2020.06.007_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-019-1089-0","article-title":"Comparing clinical outcomes of NOACs with warfarin on atrial fibrillation with Valvular heart diseases: a meta-analysis","volume":"19","author":"He","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"13","key":"10.1016\/j.tcm.2020.06.007_bib0038","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.tcm.2020.06.007_bib0039","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40268-016-0124-1","article-title":"Dabigatran versus warfarin after bioprosthesis valve replacement for the management of atrial fibrillation postoperatively: DAWA pilot study","volume":"16","author":"Dur\u00e3es","year":"2016","journal-title":"Drugs R D"},{"issue":"47","key":"10.1016\/j.tcm.2020.06.007_bib0040","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1093\/eurheartj\/ehu305","article-title":"Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial","volume":"35","author":"Breithardt","year":"2014","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.tcm.2020.06.007_bib0041","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/clc.23178","article-title":"Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial","volume":"42","author":"Guimar\u00e3es","year":"2019","journal-title":"Clin Cardiol"},{"issue":"13","key":"10.1016\/j.tcm.2020.06.007_bib0042","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/CIRCULATIONAHA.116.026714","article-title":"Edoxaban for the prevention of thromboembolism in patients with atrial fibrillation and bioprosthetic valves","volume":"135","author":"Carnicelli","year":"2017","journal-title":"Circulation"},{"issue":"38","key":"10.1016\/j.tcm.2020.06.007_bib0043","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.tcm.2020.06.007_bib0044","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-Vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.tcm.2020.06.007_bib0045","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jcin.2019.03.003","article-title":"Oral anticoagulant type and outcomes after transcatheter aortic valve replacement","volume":"12","author":"Jochheim","year":"2019","journal-title":"JACC Cardiovasc Interv [Internet]"},{"issue":"2","key":"10.1016\/j.tcm.2020.06.007_bib0046","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1911425","article-title":"A controlled trial of rivaroxaban after transcatheter aortic-valve replacement","volume":"382","author":"Dangas","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.tcm.2020.06.007_bib0047","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00392-018-1247-x","article-title":"NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation","volume":"107","author":"Geis","year":"2018","journal-title":"Clin Res Cardiol [Internet]"},{"issue":"1","key":"10.1016\/j.tcm.2020.06.007_bib0048","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcin.2016.10.023","article-title":"Apixaban in patients with atrial fibrillation after transfemoral aortic valve replacement","volume":"10","author":"Seeger","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2020.06.007_bib0049","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2018.03.008","article-title":"Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: the randomized ATLANTIS trial","volume":"200","author":"Collet","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2020.06.007_bib0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ahj.2018.07.006","article-title":"Edoxaban versus standard of care and their effects on clinical outcomes in patients having undergone transcatheter aortic valve implantation in atrial fibrillation-rationale and design of the ENVISAGE-TAVI AF trial","volume":"205","author":"Van Mieghem","year":"2018","journal-title":"Am Heart J"},{"issue":"16","key":"10.1016\/j.tcm.2020.06.007_bib0051","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.jcin.2016.06.025","article-title":"Warfarin and antiplatelet therapy versus warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement","volume":"9","author":"Abdul-Jawad Altisent","year":"2016","journal-title":"JACC Cardiovasc Interv [Internet]"},{"key":"10.1016\/j.tcm.2020.06.007_bib0052","first-page":"1","article-title":"2012 ACCF \/ AATS \/ SCAI \/ STS expert consensus document on transcatheter aortic valve replacement","author":"Holmes","year":"2012","journal-title":"Coron Artery Dis"},{"issue":"5","key":"10.1016\/j.tcm.2020.06.007_bib0053","first-page":"520","article-title":"Transcatheter aortic valve implantation: a canadian cardiovascular society position statement","volume":"28","author":"Webb","year":"2012","journal-title":"Can J Cardiol [Internet]"},{"key":"10.1016\/j.tcm.2020.06.007_bib0054","first-page":"1","article-title":"Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation","author":"Nijenhuis","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2020.06.007_bib0055","unstructured":"Cayla G, Piot C, Levy G, Rivalland F, Leclerq F, Macia J-C, et\u00a0al. Anticoagulation alone versus anticoagulation and aspirin following transcatheter aortic valve interventions (1:1) (AVATAR) [Internet]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02735902"},{"issue":"7","key":"10.1016\/j.tcm.2020.06.007_bib0056","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jacc.2016.05.069","article-title":"Feasibility of LAA closure for left atrial thrombus in patients with aortic stenosis and AF","volume":"68","author":"Parashar","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.tcm.2020.06.007_bib0057","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcin.2016.10.043","article-title":"Left atrial appendage thrombus in transcatheter aortic valve replacement: incidence, clinical impact, and the role of cardiac computed tomography","volume":"10","author":"Palmer","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.tcm.2020.06.007_bib0058","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5761\/atcs.ra.18-00014","article-title":"The efficacy and safety of the WATCHMAN device in LAA occlusion in patients with non-valvular atrial fibrillation contraindicated to oral anticoagulation: a focused review","volume":"24","author":"Majule","year":"2018","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"11","key":"10.1016\/j.tcm.2020.06.007_bib0059","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4244\/EIJV7I11A213","article-title":"Percutaneous closure of left atrial appendage after transcatheter aortic valve implantation - an interventional approach to avoid anticoagulation therapy in elderly patients: TAVI and closure of LAA to avoid warfarin therapy","volume":"7","author":"Bogunovic","year":"2012","journal-title":"EuroIntervention"},{"issue":"2","key":"10.1016\/j.tcm.2020.06.007_bib0060","doi-asserted-by":"crossref","first-page":"126","DOI":"10.15420\/icr.2011.9.2.126","article-title":"Transcatheter aortic valve replacement and left atrial appendage occlusion - a stitch in time?","volume":"9","author":"Gafoor","year":"2014","journal-title":"Interv Cardiol Rev"},{"key":"10.1016\/j.tcm.2020.06.007_bib0061","unstructured":"Kapadia S, The Cleveland Clinic. WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement [Internet]. Available from:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03173534"},{"issue":"20","key":"10.1016\/j.tcm.2020.06.007_bib0062","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1602002","article-title":"Rate control versus rhythm control for atrial fibrillation after cardiac surgery","volume":"374","author":"Gillinov","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.tcm.2020.06.007_bib0063","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/imj.14281","article-title":"Management of atrial fibrillation after cardiac surgery","volume":"49","author":"Conte","year":"2019","journal-title":"Intern Med J"},{"issue":"21","key":"10.1016\/j.tcm.2020.06.007_bib0064","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1093\/eurheartj\/ehs290","article-title":"Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and\/or valvular heart disease plus atrial fibrillation: Final results of the PRAGUE-12 randomized multicentre study","volume":"33","author":"Budera","year":"2012","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.tcm.2020.06.007_bib0065","first-page":"350","article-title":"Atrial fibrillation ablation in patients undergoing aortic valve replacement","volume":"21","author":"Malaisrie","year":"2012","journal-title":"J Heart Valve Dis"},{"issue":"1","key":"10.1016\/j.tcm.2020.06.007_bib0066","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/europace\/eux275","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary","volume":"20","author":"Calkins","year":"2018","journal-title":"Europace [Internet]"},{"issue":"5","key":"10.1016\/j.tcm.2020.06.007_bib0067","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med [Internet]"},{"key":"10.1016\/j.tcm.2020.06.007_bib0068","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jacc.2012.02.063","article-title":"Does new onset atrial fibrillation have a true impact on the incidence of stroke after transcatheter aortic valve implantation?","volume":"60","author":"Salinas","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.tcm.2020.06.007_bib0069","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1161\/CIRCULATIONAHA.112.110981","article-title":"Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation","volume":"126","author":"Nombela-Franco","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.tcm.2020.06.007_bib0070","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jcin.2015.06.010","article-title":"Baseline characteristics and prognostic implications of pre-existing and new-onset atrial fibrillation after transcatheter aortic valve implantation: results from the FRANCE-2 registry","volume":"8","author":"Chopard","year":"2015","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173820300864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173820300864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T05:00:26Z","timestamp":1760936426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173820300864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1050173820300864"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2020.06.007","relation":{},"ISSN":["1050-1738"],"issn-type":[{"type":"print","value":"1050-1738"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of atrial fibrillation after transcatheter aortic valve replacement: Challenges and therapeutic considerations","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2020.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}